Drug intelligence / Profile preview

atopiclair

Development stage
Phase 4
Lead developer
Sinclair
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Atopiclair is a non-steroidal topical emollient formulated as a cream or lotion for the management of atopic dermatitis (eczema), allergic contact dermatitis, and other dry or sensitive skin conditions. It is clinically proven to relieve symptoms such as itching, burning, and pain associated with these dermatological disorders. The product contains glycyrrhetinic acid (derived from licorice root) with anti-inflammatory and anti-itch properties; hyaluronic acid for moisturizing; shea butter and other lipids to restore the skin barrier; along with additional soothing ingredients like bisabolol and allantoin. Atopiclair works by hydrating the skin and restoring its natural barrier function without using steroids or parabens. It can be used during both flare-ups and remission phases of eczema in adults and children over 6 months old[1][3][5][6][10].

Brand names
AtopiclairAtraproAurstatAVO CreamBiafine
Other names
emollient creamemollient lotionemollient gelemollient ointment
02

Targets

HSD11B2 (11β-HSD2)

Beyond the preview

Go deeper on atopiclair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on atopiclair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call